efrotomycin has been researched along with Body-Weight* in 3 studies
3 other study(ies) available for efrotomycin and Body-Weight
Article | Year |
---|---|
Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity.
A radiochemical method was developed to estimate cholyltaurine hydrolase potentials and rates of cholyltaurine hydrolysis in chicken intestinal homogenates. This method was used to monitor the effects of antibiotic feed additives on cholyltaurine hydrolase activity. Avoparcin, bacitracin methylenedisalisylic acid, efrotomycin, lincomycin, penicillin G procaine, and virginiamycin improved rate of weight gain and feed conversion of chicks and decreased cholyltaurine hydrolase activity in ileal homogenates relative to those of nonmedicated control birds. The results provided the first evidence that feeding selected antibiotics at subtherapeutic levels can affect bile acid-transforming enzymes in small-intestinal homogenates. The inverse relationship between growth performance and cholyltaurine hydrolase activity raises the possibility that specific inhibitors of this enzyme may promote weight gain and feed conversion in livestock and thereby reduce or eliminate the need for antibiotic feed additives. Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Bacitracin; Bacteria; Body Weight; Chickens; Food Additives; Intestine, Small; Male; Polymyxin B; Pyridones; Taurocholic Acid | 1987 |
Effect of efrotomycin on gain and feed efficiency for pigs from weaning until market weight.
Six studies involving 700 pigs were conducted in five separate swine research facilities to evaluate weight gain and efficiency of feed utilization in pigs fed the antibiotic efrotomycin. Pigs averaging 8.4 kg at the beginning of the studies were fed fortified corn-soybean meal diets that contained efrotomycin at 0, 2, 4, 8 or 16 ppm for an average of 120 d to market weight, about 92.1 kg. Pigs fed efrotomycin gained 5.9 to 8.9% faster (P less than .01) and were 1.7 to 4.0% more efficient (P less than .01) than those fed control diets. The improvement in growth rate was linear from 2 through 16 ppm, while feed efficiency (gain/feed) plateaued at 4 ppm efrotomycin. Treatment X study interactions were not significant for average daily gain or feed efficiency, showing that the response to efrotomycin was similar in each study. These studies indicate that efrotomycin is effective in improving gain and efficiency of feed utilization in swine from weaning until market weight. Topics: Administration, Oral; Animal Feed; Animals; Anti-Bacterial Agents; Body Weight; Female; Male; Pyridones; Swine | 1987 |
In vitro and in vivo evaluations of the antibiotic efrotomycin.
Experiments were conducted to determine the potential of the antibiotic efrotomycin as a growth permittant for poultry and to further elucidate the mode of action of antimicrobial agents for that purpose. Efrotomycin as the semipurified antibiotic and as fermentation solids demonstrated excellent activity against Clostridium perfringens at .1 to .2 ppm based on suppression of gas production in an anaerobic tube test. Supplementing a soybean protein and sucrose-based diet with levels of 2.2, 11, and 55 ppm of the antibiotic, from the two sources each with two different purities, improved weight gain of chicks an average of 23% and improved feed efficiency an average of 13% at the higher levels (all P less than .01). Computed indexes for each antibiotic treatment, which represent the combined effects of both weight gain and feed efficiency, showed that a maximum response was generally obtained at the 11 ppm level and that the antibiotic as fermentation solids was slightly more active than the semipurified material. Supplementing the soybean protein and sucrose-based diet with levels of 1.1, 5.5, 16.5, and 55 ppm of efrotomycin reduced the numbers of C. perfringens organisms in ileal contents of chicks (all P less than .01). The effects were dose-related. Control chicks in this experiment averaged greater than 7.7 log10 of C. perfringens counts per gram of contents. The results of these experiments show that efrotomycin has excellent growth-permittant activity and the activity correlates with the antibacterial activity against C. perfringens. Topics: Animals; Anti-Bacterial Agents; Body Weight; Chickens; Clostridium perfringens; Diet; Energy Metabolism; Food Additives; Intestine, Small; Male; Pyridones | 1983 |